BRK.B
47
2
ALLE
37
-4
VIX
11
-2
CMA
52
2
GT
49
-3
TGNA
66
2
SNA
60
2
EL
55
-3
CTSH
49
-2
LRCX
55
-6
WDC
49
-4
HUM
43
-4
PYPL
31
2
CF
44
-3
AA
53
5
REGN
65
2
UNM
70
2
ALL
50
2
DVA
73
2
HRB
85
-2
BRK.B
47
2
ALLE
37
-4
VIX
11
-2
CMA
52
2
GT
49
-3
TGNA
66
2
SNA
60
2
EL
55
-3
CTSH
49
-2
LRCX
55
-6
WDC
49
-4
HUM
43
-4
PYPL
31
2
CF
44
-3
AA
53
5
REGN
65
2
UNM
70
2
ALL
50
2
DVA
73
2
HRB
85
-2
Financhill
Back

GT Biopharma Vs. Outlook Therapeutics Industry Stock Comparison

Sell
16

GTBP
GT Biopharma

Last Price:
3.10
Seasonality Move:
4.06%
Sell
44

OTLK
Outlook Therapeutics

Last Price:
7.78
Seasonality Move:
22.9%
Sell
16
GT Biopharma (GTBP) is a Sell

Is GT Biopharma a Buy, Sell or Hold?

  • The current GT Biopharma [GTBP] share price is $3.12. The Score for GTBP is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • GTBP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
44
Outlook Therapeutics (OTLK) is a Sell

Is Outlook Therapeutics a Buy, Sell or Hold?

  • The current Outlook Therapeutics [OTLK] share price is $7.78. The Score for OTLK is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • OTLK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GTBP Stock Price Chart

What is GT Biopharma's stock price today?

  • The GT Biopharma share price today is $3.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTBP is experiencing selling pressure, which indicates risk of future bearish movement.

OTLK Stock Price Chart

What is Outlook Therapeutics's stock price today?

  • The Outlook Therapeutics share price today is $7.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OTLK is experiencing buying pressure, which is a positive indicator for future bullish movement.

GTBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 40.36 Sell
Chaikin Money Flow: -6962 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.12 - 3.68) Sell
Bollinger Bands (100): (3.4 - 6.18) Sell

OTLK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 44.35 Sell
Chaikin Money Flow: 115028 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.71 - 8.67) Sell
Bollinger Bands (100): (7.41 - 9.11) Sell

GTBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.19 Sell
20-day SMA: 3.3 Sell
50-day SMA: 3.88 Sell
200-day SMA: 6.17 Sell
8-day EMA: 3.19 Sell
20-day EMA: 3.34 Sell
50-day EMA: 3.83 Sell
200-day EMA: 8.26 Sell

OTLK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.6 Buy
20-day SMA: 8.11 Sell
50-day SMA: 8.34 Sell
200-day SMA: 9.87 Sell
8-day EMA: 7.68 Buy
20-day EMA: 8.02 Sell
50-day EMA: 8.28 Sell
200-day EMA: 11.33 Sell

GT Biopharma Earnings Growth & GTBP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $3.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.

Outlook Therapeutics Earnings Growth & OTLK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.35 per share, an increase this year of $0.49 per share, and an increase next year of $1.74 per share.

GT Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Outlook Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):